Agilent Technologies Current Ratio 2010-2025 | A
Current and historical current ratio for Agilent Technologies (A) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Agilent Technologies current ratio for the three months ending January 31, 2025 was 2.20.
| Agilent Technologies Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-01-31 | $4.11B | $1.87B | 2.20 |
| 2024-10-31 | $3.96B | $1.90B | 2.09 |
| 2024-07-31 | $4.26B | $2.39B | 1.78 |
| 2024-04-30 | $4.20B | $1.96B | 2.15 |
| 2024-01-31 | $4.34B | $1.62B | 2.68 |
| 2023-10-31 | $4.19B | $1.60B | 2.61 |
| 2023-07-31 | $4.03B | $1.76B | 2.29 |
| 2023-04-30 | $3.95B | $1.67B | 2.37 |
| 2023-01-31 | $4.08B | $1.94B | 2.11 |
| 2022-10-31 | $3.78B | $1.86B | 2.03 |
| 2022-07-31 | $3.69B | $1.90B | 1.94 |
| 2022-04-30 | $3.64B | $1.81B | 2.01 |
| 2022-01-31 | $3.47B | $1.58B | 2.19 |
| 2021-10-31 | $3.80B | $1.71B | 2.22 |
| 2021-07-31 | $3.63B | $1.72B | 2.11 |
| 2021-04-30 | $3.51B | $1.76B | 2.00 |
| 2021-01-31 | $3.48B | $1.69B | 2.07 |
| 2020-10-31 | $3.42B | $1.47B | 2.33 |
| 2020-07-31 | $3.25B | $1.31B | 2.47 |
| 2020-04-30 | $3.17B | $1.95B | 1.63 |
| 2020-01-31 | $3.10B | $1.89B | 1.64 |
| 2019-10-31 | $3.19B | $2.08B | 1.53 |
| 2019-07-31 | $3.46B | $1.62B | 2.13 |
| 2019-04-30 | $3.81B | $1.12B | 3.41 |
| 2019-01-31 | $3.71B | $1.10B | 3.39 |
| 2018-10-31 | $3.85B | $1.17B | 3.29 |
| 2018-07-31 | $3.67B | $1.01B | 3.62 |
| 2018-04-30 | $4.53B | $1.37B | 3.32 |
| 2018-01-31 | $4.40B | $1.36B | 3.23 |
| 2017-10-31 | $4.17B | $1.26B | 3.30 |
| 2017-07-31 | $4.00B | $1.24B | 3.22 |
| 2017-04-30 | $3.80B | $1.19B | 3.20 |
| 2017-01-31 | $3.64B | $1.09B | 3.34 |
| 2016-10-31 | $3.64B | $0.95B | 3.85 |
| 2016-07-31 | $3.53B | $1.15B | 3.07 |
| 2016-04-30 | $3.49B | $1.13B | 3.08 |
| 2016-01-31 | $3.40B | $0.95B | 3.59 |
| 2015-10-31 | $3.69B | $0.98B | 3.78 |
| 2015-07-31 | $3.48B | $0.85B | 4.08 |
| 2015-04-30 | $3.62B | $0.93B | 3.89 |
| 2015-01-31 | $3.65B | $0.93B | 3.94 |
| 2014-10-31 | $5.51B | $1.69B | 3.26 |
| 2014-07-31 | $4.83B | $1.58B | 3.06 |
| 2014-04-30 | $5.38B | $1.72B | 3.13 |
| 2014-01-31 | $5.07B | $1.55B | 3.28 |
| 2013-10-31 | $4.98B | $1.60B | 3.11 |
| 2013-07-31 | $4.58B | $1.55B | 2.96 |
| 2013-04-30 | $4.82B | $1.91B | 2.53 |
| 2013-01-31 | $4.71B | $1.85B | 2.55 |
| 2012-10-31 | $4.63B | $1.89B | 2.45 |
| 2012-07-31 | $4.21B | $2.09B | 2.02 |
| 2012-04-30 | $6.01B | $1.84B | 3.28 |
| 2012-01-31 | $5.72B | $1.71B | 3.35 |
| 2011-10-31 | $5.57B | $1.84B | 3.03 |
| 2011-07-31 | $5.22B | $1.51B | 3.47 |
| 2011-04-30 | $5.10B | $1.59B | 3.20 |
| 2011-01-31 | $4.60B | $1.41B | 3.27 |
| 2010-10-31 | $6.17B | $3.08B | 2.00 |
| 2010-07-31 | $5.74B | $2.92B | 1.97 |
| 2010-04-30 | $5.71B | $2.71B | 2.11 |
| 2010-01-31 | $5.52B | $2.55B | 2.17 |
| 2009-10-31 | $3.96B | $1.12B | 3.53 |
| 2009-07-31 | $2.90B | $0.99B | 2.92 |
| 2009-04-30 | $2.88B | $1.10B | 2.62 |
| 2009-01-31 | $3.01B | $1.13B | 2.66 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $30.897B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $230.702B | 27.74 |
| Boston Scientific (BSX) | United States | $154.217B | 38.61 |
| Stryker (SYK) | United States | $145.561B | 30.44 |
| EssilorLuxottica (ESLOY) | France | $133.244B | 0.00 |
| Medtronic (MDT) | Ireland | $107.028B | 15.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $52.631B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.943B | 27.26 |
| ResMed (RMD) | United States | $35.287B | 26.50 |
| GE HealthCare Technologies (GEHC) | United States | $31.763B | 15.08 |
| Terumo (TRUMY) | Japan | $29.152B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.100B | 17.21 |
| Insulet (PODD) | United States | $18.209B | 77.71 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.901B | 11.50 |
| Baxter (BAX) | United States | $15.608B | 11.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.425B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.970B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.395B | 18.18 |
| Bio-Rad Laboratories (BIO) | United States | $6.728B | 22.75 |
| Prestige Consumer Healthcare (PBH) | United States | $4.111B | 19.62 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.444B | 9.86 |
| ICU Medical (ICUI) | United States | $3.347B | 28.51 |
| Haemonetics (HAE) | United States | $3.139B | 14.77 |
| Envista Holdings (NVST) | United States | $2.876B | 23.90 |
| GN Store Nord (GNNDY) | Denmark | $2.071B | 17.15 |
| QuidelOrtho (QDEL) | United States | $1.868B | 15.64 |
| LeMaitre Vascular (LMAT) | United States | $1.817B | 40.63 |
| AtriCure (ATRC) | United States | $1.439B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.359B | 21.40 |
| Neogen (NEOG) | United States | $1.224B | 15.67 |
| AdaptHealth (AHCO) | United States | $1.173B | 11.30 |
| Kestra Medical Technologies (KMTS) | United States | $1.159B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.150B | 0.00 |
| InMode (INMD) | Israel | $0.991B | 9.08 |
| Phibro Animal Health (PAHC) | United States | $0.791B | 12.13 |
| Evolus (EOLS) | United States | $0.774B | 0.00 |
| Owens & Minor (OMI) | United States | $0.632B | 5.38 |
| Curaleaf Holdings (CURLF) | Canada | $0.618B | 0.00 |
| CeriBell (CBLL) | United States | $0.583B | 0.00 |
| Valneva SE (VALN) | France | $0.557B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.539B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.470B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.442B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.437B | 0.00 |
| Omeros (OMER) | United States | $0.397B | 0.00 |
| Surmodics (SRDX) | United States | $0.386B | 0.00 |
| SNDL (SNDL) | Canada | $0.355B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.348B | 15.09 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.312B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.290B | 26.18 |
| Sanara MedTech (SMTI) | United States | $0.288B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.265B | 47.20 |
| Sanuwave Health (SNWV) | United States | $0.265B | 0.00 |
| Cerus (CERS) | United States | $0.249B | 0.00 |
| ZimVie (ZIMV) | United States | $0.247B | 14.80 |
| Canopy Growth (CGC) | Canada | $0.234B | 0.00 |
| Quanterix (QTRX) | United States | $0.225B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.221B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Biote (BTMD) | United States | $0.178B | 4.06 |
| Utah Medical Products (UTMD) | United States | $0.172B | 13.83 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| Brainsway (BWAY) | Israel | $0.164B | 51.24 |
| Organigram Global (OGI) | Canada | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 17.91 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.118B | 0.00 |
| Exagen (XGN) | United States | $0.113B | 0.00 |
| Agape ATP (ATPC) | $0.105B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.103B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.081B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.61 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| United Health Products (UEEC) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.047B | 0.00 |
| Apyx Medical (APYX) | United States | $0.044B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.041B | 59.50 |
| Safety Shot (SHOT) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 11.31 |
| Nephros (NEPH) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |